Another New Alzheimer’s Drug: What Promising Trial Results Mean for Treatment
Findings suggest that the amyloid-targeting drug candidate slows cognitive decline in some people, but questions remain over its potential side effects
Sara Reardon is a freelance journalist based in Bozeman, Mont. She is a former staff reporter at Nature, New Scientist and Science and has a master's degree in molecular biology.
Findings suggest that the amyloid-targeting drug candidate slows cognitive decline in some people, but questions remain over its potential side effects
These elements, dubbed “UNICORNs,” sit close to genes that affect smell, sleep and ways that people and other mammals interact with their surroundings
A federal judge in Texas ruled to withdraw the Food and Drug Administration’s approval of the abortion drug mifepristone, potentially making medication abortion less accessible nationwide...
As more people turn to chat-based AIs for medical advice, it remains to be seen how these tools stack up against—or could complement—human doctors
The risks associated with a bone marrow transplant used to treat HIV mean the procedure is unlikely to be widely used in its current form
With cases declining in the U.S. and Europe, here are some scenarios of how the outbreak might play out
An unvaccinated person in New York State’s Rockland County developed paralysis from a polio infection, emphasizing the need to target vaccination efforts to vulnerable communities
The virus circulating in the current outbreak has mutated 50 times in the past four years
The model, which uses machine learning to track the fitness of different viral strains, accurately predicted the rise of Omicron’s BA.2 subvariant and the Alpha variant
States that outlaw abortions after a certain number of weeks could make it difficult or impossible to terminate a pregnancy because of a serious genetic disorder
Results from a large study suggest that vaccines offer less protection against lingering symptoms than expected
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
A CDC database of sewage data from communities around the nation could provide earlier warning of outbreaks and new viral variants
A handful of experiments are raising questions about whether clumps of cells and disembodied brains could be sentient and how scientists would know if they were
It depends, but vaccinated people should generally wait five days after exposure before taking an antigen test. Here’s why
Wealthy countries have bought up most of the available vaccine doses for booster shots but still have far more than they need
If the Supreme Court overturns Roe v. Wade in a Mississippi abortion case, numerous state laws will interfere with key biological and social decisions during pregnancy
Experts explain what this treatment involves, who needs it and how to get it
A tool built by the U.S. Geological Survey suggests that the number of fatalities may range from 10,000 to 100,000 or more
Mutations that make a virus more transmissible are only part of the equation
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account